Latest filing published 25 Mar 2015 for Merrimack Pharmaceuticals INC, €16k.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Robert J. Mulroy: trading record in brief
Robert J. Mulroy is a declared insider of Merrimack Pharmaceuticals Inc, with filings sourced from SEC (Form 4). In total, 31 filings cover trades dated from 3 April 2012 to 24 March 2015.
Market trades split into 2 purchases (€130k) and 6 sales (€4.5M). Taken together, the sales exceed the purchases by €4.4M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 15 option exercises. 2015 to date brings no purchases and 4 sales.
The record was last updated on 25 March 2015 with an option exercise (€16k) in Merrimack Pharmaceuticals Inc. The clock since the last published purchase (7 May 2014) now reads 4,569 days. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Robert J. Mulroy
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 10,400 shares@ US$1.71Common StockSEC:0001179110-15-005436:0
- 10,400 shares@ US$11.69Common StockSEC:0001179110-15-005436:1
- 273,968 shares@ US$1.71Common StockSEC:0001179110-15-005436:2
- 103,968 shares@ US$11.71Common StockSEC:0001179110-15-005436:3
- 52,985 shares@ US$2.47Common StockSEC:0001179110-15-005436:4
- 26,689 shares@ US$2.59Common StockSEC:0001179110-15-005436:5
- 94,338 shares@ US$2.12Common StockSEC:0001179110-15-005436:6
- 22,385 shares@ US$1.71Common StockSEC:0001179110-15-004510:0
- 22,385 shares@ US$12.50Common StockSEC:0001179110-15-004510:1
- 150,000 shares@ US$1.71Common StockSEC:0001179110-15-003044:0
- 150,000 shares@ US$10.94Common StockSEC:0001179110-15-003044:1
- 175,000 shares@ US$1.25Common StockSEC:0001179110-14-017783:0
- 175,000 shares@ US$9.85Common StockSEC:0001179110-14-017783:1
- 49,163 shares@ US$1.25Common StockSEC:0001179110-14-017783:2
- 25,000 shares@ US$9.73Common StockSEC:0001179110-14-017783:3
- 25,837 shares@ US$1.25Common StockSEC:0001179110-14-017783:4
- 43,247 shares@ US$1.71Common StockSEC:0001179110-14-017783:5
- 19,832 shares@ US$1.25Common StockSEC:0001179110-14-013444:0
- 280,168 shares@ US$1.25Common StockSEC:0001179110-14-013202:0
- 5,000 shares@ US$6.31Common StockSEC:0001179110-14-007829:0Canonical exit: 3 Aug 2014 (T+90)
- 58,290 shares0Common StockSEC:0001179110-14-002710:0
- 9,715 shares0Common StockSEC:0001179110-14-002710:1
- 33,100 shares@ US$4.42Common StockSEC:0001179110-13-017459:0Canonical exit: 4 Mar 2014 (T+90)
- 50,000 shares@ US$2.19Common StockSEC:0001179110-13-007790:0
- 7,443 shares0Common StockSEC:0001179110-13-002571:0
25 of 31 declarations
